Department of Urology, Careggi Hospital, University of Florence, Florence, Italy.
Assisted Reproductive Technology Centre, Careggi Hospital, University of Florence, Florence, Italy.
Andrology. 2020 Sep;8(5):1256-1264. doi: 10.1111/andr.12816. Epub 2020 Jun 8.
Recently, alterations in miRNAs expression profile in semen have been linked to damaged spermatogenesis, suggesting miRNAs could be used as potential infertility biomarkers. In previous animal studies, miR-20a-5p was found to be down-expressed in low motile spermatozoa, implying its potential target of genes associated with cell apoptosis.
To investigate miR-20a-5p expression in blood plasma of patients suffering from non-obstructive azoospermia (NOA), compared to normozoospermic controls.
Between January 2018 and December 2019, from 52 infertile couples eligible for the study, 24 couples were finally enrolled in this monocentric observational prospective pilot study. Patients were included into two groups: Group 1 comprised men with NOA (n = 14) and Group 2 fertile men partners of women with female tubal factor infertility (n = 10). All NOA patients underwent testicular sperm extraction. The expression of circulating miR-20a-5p in plasma samples was assessed by RT-qPCR. A relative quantification strategy was adopted using the 2 method to calculate the target miR-20a-5p expression with respect to miR-16-5p as endogenous control.
Median blood plasma miR-20a-5p was significantly higher in patients affected by NOA (0.16 2 , range: 0.05-0.79 2 ) than in fertile controls (0.06 2 , range: 0.04-0.10 2 ), P < .001. MiR-20a-5p was positively correlated with follicle-stimulating hormone (FSH) (r = -0.490, P = .015) and luteinizing hormone (LH) (r = -0.462, P = .023), and negatively correlated with serum total testosterone (TT) (r = -0.534, P = .007) and right and left testicular size (r = -0.473, P = .020 and r = -0.471, P = .020, respectively). Successful sperm retrieval (SR) rate was 50.0%. Median value of miR-20a-5p did not differ significantly among patients with successful SR and those with negative SR. Testicular histological examination showed: hypospermatogenesis in 6/14 (42.8%), maturation arrest in 4/14 (28.6%), sertoli cell-only syndrome in 4/14 (28.6%). No significant differences in miR-20a-5p were found between histopathological patterns (P > .05).
MiR-20a-5p could represent a novel non-invasive diagnostic biomarker of male infertility.
最近,精液中 miRNAs 表达谱的改变与受损的精子发生有关,这表明 miRNAs 可以作为潜在的不育生物标志物。在以前的动物研究中,发现 miR-20a-5p 在低活力精子中表达下调,暗示其潜在的靶基因与细胞凋亡有关。
研究非梗阻性无精子症(NOA)患者血浆中 miR-20a-5p 的表达,与正常精子症对照组进行比较。
2018 年 1 月至 2019 年 12 月,从 52 对符合研究条件的不孕夫妇中,最终有 24 对夫妇纳入这项单中心前瞻性观察性试点研究。患者分为两组:组 1 包括 14 名患有 NOA 的男性(n=14),组 2 为女性输卵管因素不孕的男性伴侣(n=10)。所有 NOA 患者均接受了睾丸精子提取术。通过 RT-qPCR 评估血浆样本中循环 miR-20a-5p 的表达。采用 2 法进行相对定量策略,以 miR-16-5p 作为内参计算目标 miR-20a-5p 的表达。
NOA 患者的中位血浆 miR-20a-5p 水平显著高于正常生育对照组(0.162,范围:0.05-0.792),P<0.001。miR-20a-5p 与卵泡刺激素(FSH)(r=-0.490,P=0.015)和黄体生成素(LH)(r=-0.462,P=0.023)呈正相关,与血清总睾酮(TT)(r=-0.534,P=0.007)和右侧和左侧睾丸大小(r=-0.473,P=0.020 和 r=-0.471,P=0.020)呈负相关。精子获取成功(SR)率为 50.0%。SR 成功与 SR 失败的患者的 miR-20a-5p 中位数无显著差异。睾丸组织学检查显示:14 例中有 6 例(42.8%)为低精子发生症,4 例(28.6%)为成熟阻滞,4 例(28.6%)为单纯支持细胞综合征。组织病理学模式之间的 miR-20a-5p 无显著差异(P>0.05)。
miR-20a-5p 可能成为男性不育的一种新的非侵入性诊断生物标志物。